JPM
Tiny buyer, big bank
Spirepoint Private Client LLC decided JPMorgan Chase wasn’t quite heavy enough in the portfolio, so it added 3,449 shares and bumped its stake 13.2% higher. By quarter-end, the firm was sitting on 29,562 shares worth roughly $9.525 million. Not exactly a “sound the alarms” trade, but still a clean little breadcrumb for anyone tracking who’s nibbling on Wall Street’s favorite banking giant.
Why this matters
On its own, one fund buying more JPM probably won’t move the needle much. But in context, it adds to a pretty loud chorus around the stock: JPM just posted a strong Q1 beat, analysts have been lifting price targets, and the bank even got a regulatory weight off its back when the OCC terminated a March 2024 consent order tied to its trade-surveillance program.
The catch, because there’s always a catch
Management did trim full-year net interest income guidance and basically reminded everyone that the stock isn’t cheap. And insider selling has been noticeable, including Rule 10b5-1 sales from executives. So the setup is a little “good news, but don’t get too comfy.”
Big picture: this isn’t the kind of filing that changes the JPM story by itself. But it does show one more investor leaning into the name while the earnings momentum is still doing the heavy lifting.